Peter Black

VCH Clinical Title(s)

Urologic Oncologist

Research Focus

Prostate Cancer Surgery and Rehabilitation Cancers Bladder Cancers Kidney Cancer

Degrees / Designations

MD, FACS, FRCSC

Contact Info

peter.black@ubc.ca

pcvblack

Biography

Dr. Peter Black is the director of the Vancouver Prostate Centre and a professor in the Department of Urologic Sciences at the University of British Columbia (UBC). His clinical subspecialty interest is in the treatment of urologic cancers, especially bladder and prostate cancer. He maintains a grant-funded translational research program in urothelial carcinoma with a focus on genomic analysis of response to chemotherapy, mechanisms of resistance to chemotherapy, and novel targeted therapies for bladder cancer.

Dr. Black has received a number of awards including Best Clinical Paper Published in Literature by the European Association of Urology in 2016, the David A. Swanson Distinguished Alumnus Award from MD Anderson Cancer Center in 2017 and the Distinguished Achievement Award for Excellence in Clinical or Applied Research by the UBC Faculty of Medicine in 2013. He served on the Board of Directors of the Société Internationale d'Urologie from 2013-2019 and is general secretary of the International Bladder Cancer Network.

Research Studies

Prostate Cancer, Sexual Health

News and Awards

Publications

Clinical cancer research : an official journal of the American Association for Cancer Research -
Molecular Characterization of Neuroendocrine-like Bladder Cancer.
Batista da Costa J, Gibb EA, Bivalacqua TJ, Liu Y, Oo HZ, Miyamoto DT, Alshalalfa M, Davicioni E, Wright J, Dall'Era MA, Douglas J, Boormans JL, Van der Heijden MS, Wu CL, van Rhijn BWG, Gupta S, Grivas P, Mouw KW, Murugan P, Fazli L, Ra S, Konety BR, Seiler R, Daneshmand S, Mian OY, Efstathiou JA, Lotan Y, Black PC
European urology -
Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors.
Lotan Y, Boorjian SA, Zhang J, Bivalacqua TJ, Porten SP, Wheeler T, Lerner SP, Hutchinson R, Francis F, Davicioni E, Svatek RS, Chen CL, Black PC, Gibb EA
European urology -
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.
Necchi A, Raggi D, Gallina A, Ross JS, Farè E, Giannatempo P, Marandino L, Colecchia M, Lucianò R, Bianchi M, Colombo R, Salonia A, Gandaglia G, Fossati N, Bandini M, Pederzoli F, Capitanio U, Montorsi F, de Jong JJ, Dittamore R, Liu Y, Davicioni E, Boormans JL, Briganti A, Black PC, Gibb EA
Canadian Urological Association journal = Journal de l'Association des urologues du Canada -
Building a Canadian Translational Bladder Cancer Research Network.
Koti M, Berman DM, Siemens DR, Lange D, Wang E, Toren P, Eigl BJ, Hardy C, Purves R, Fradet V, Fradet Y, Mansure J, Kassouf W, Black PC,
JAMA oncology -
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.
Klotz L, Chin J, Black PC, Finelli A, Anidjar M, Bladou F, Mercado A, Levental M, Ghai S, Chang SD, Milot L, Patel C, Kassam Z, Moore C, Kasivisvanathan V, Loblaw A, Kebabdjian M, Earle CC, Pond GR, Haider MA

Peter Black

Biography

Research Studies

Sexual Recovery After Prostate Cancer

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer (EMMPC)

News and Awards

Welcoming the new M. H. Mohseni Institute of Urologic Sciences to VCHRI

Prostate Centre director’s new vision for urologic sciences research

Innovation and Translational Research Awards 2024 Recipients

Life turned upside down: Father of three faces reality of post-cancer diagnosis

Ask the experts: Why should I carve out research time for social media?

Publications

Molecular Characterization of Neuroendocrine-like Bladder Cancer.

Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors.

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.

Building a Canadian Translational Bladder Cancer Research Network.

Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.

Are you a researcher?